Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Filings indexed 1,179 across all filing types
Latest filing 2020-05-26 AGM Information
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Uchwały NWZA Selvita SA_26.05.2020
AGM Information Classification · 99% confidence The document is explicitly titled "PROTOKOŁ NADZWYCZAJNEGO WALNEGO ZGROMADZENIA SELVITA S.A." (Minutes of the Extraordinary General Meeting of SELVITA S.A.). It details the proceedings, voting on resolutions (Uchwała Nr 1, Uchwała Nr 2, Uchwała Nr 3, Uchwała Nr 4), including the election of the meeting chairman and the scrutiny committee, and crucially, the resolution regarding a capital increase (Uchwała Nr 4) involving the issuance of new shares (Akcji Serii C) and the exclusion of pre-emptive rights. This content directly relates to the formal proceedings and resolutions passed during a shareholder meeting, which aligns best with the 'AGM Information' category, even though it is an Extraordinary General Meeting (EGM) rather than an Annual General Meeting (AGM). Since there is no specific code for EGM Minutes, AGM-R is the closest fit for formal meeting documentation.
2020-05-26 Polish
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Selvita S.A. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document text is very short (688 characters) and explicitly states that the Management Board ('Zarząd') of Selvita S.A. is enclosing ('przekazuje w załączeniu') the content of the resolutions ('treść uchwał') adopted by the Extraordinary General Meeting ('Nadzwyczajne Walne Zgromadzenie Spółki') held on May 26, 2020. This content includes voting details (votes for, against, abstained). Since the document is an announcement transmitting the results of a shareholder vote from a general meeting, it directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not the full AGM presentation (AGM-R) or a proxy solicitation document (PSI), but the official results announcement.
2020-05-26 Polish
Raport Q12020 Grupa Kapitałowa Selvita Informacje dodatkowe
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany raport kwartalny' (Consolidated Quarterly Report) for Q1 2020 for Grupa Kapitałowa Selvita. It contains detailed financial statements, balance sheets, income statements, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-26 Polish
Skonsolidowane sprawozdnaie finansowe Grupy Kapitałowej Selvita Q12020
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowane sprawozdanie finansowe' (Consolidated Financial Statement) for the period 01.01.2020 to 31.03.2020. It contains detailed financial statements (Statement of Comprehensive Income, Statement of Financial Position) and extensive explanatory notes (Noty objaśniające). Since it covers a period shorter than a full fiscal year (a quarter) and includes substantive financial data, it is classified as an Interim/Quarterly Report. Q1 2020
2020-05-26 Polish
Jednostkowe sprawozdanie finansowe Selvita SA Q12020
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for Selvita S.A. covering the period from 01.01.2020 to 31.03.2020. It contains detailed financial statements, including the balance sheet, profit and loss account, and cash flow statement, as well as accounting policies and notes. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2020
2020-05-26 Polish
Rekomendowanie projektu do dofinansowania przez NCBiR - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement from the Management Board ('Zarząd') of Selvita S.A. regarding a project selected for co-financing under the Operational Programme Intelligent Development 2014-2020. It details the project's goal (developing AI-based TCR technology), the total value, and the recommended funding amount. This type of announcement, concerning fundraising, grants, or significant financing activities, aligns best with the Capital/Financing Update category. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific announcement about securing funding/grant money, 'CAP' is the most appropriate classification.
2020-05-25 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.